RecruitingNot ApplicableNCT04522193

Dumping Syndrome and Esophageal Atresia

Physiopathology of Dumping Syndrome in Esophageal Atresia

Sponsor

University Hospital, Lille

Enrollment

15 participants

Start Date

Feb 23, 2024

Study Type

INTERVENTIONAL

Conditions

Oesophageal Atresia Dumping syndrome

Summary

Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection difficult to diagnose, because it only occurs after meals and can be inconstantly present. To date, their is only symptomatic treatment for DS. This study aims to understand its pathological mechanisms so as to better treat it and avoid its consequences. Oesophageal atresia patients enrolled in this study will benefit from a continuous glycemic monitoring, a continuous cardiac monitoring, and an a gastric emptying scintigraphy at the age of 3 months

Eligibility

Min Age: 2 MonthsMax Age: 3 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Glycemic Holter, a medical device called Holter ECG, and others for people with dumping syndrome and oesophageal atresia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 2 Months to 3 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGlycemic Holter

Continuous glycaemia monitoring,

RADIATIONgastric emptying scintigraphy

Fasting administration of a Technecium-labelled milk bottle and quantification of the remaining radioactivity by a camera every 30 minutes for 4 hours.

DEVICEHolter ECG

continuous cardiac monitoring